Annual Results Results Snapshot
Figures in Million
Consolidate Annual Results
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Mar'18
Mar'17
Net Sales
1,286.43
1,391.41
1,108.57
620.74
751.44
845.78
738.44
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,286.43
1,391.41
1,108.57
620.74
751.44
845.78
738.44
Raw Material Cost
676.89
817.26
660.31
338.50
449.92
501.99
427.68
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
214.67
214.89
210.93
175.56
175.15
183.27
168.57
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
106.31
95.69
107.72
56.70
28.55
18.93
16.55
Selling and Distribution Expenses
544.61
516.66
467.26
399.76
433.90
437.19
436.26
Other Expenses
-31.91
-30.93
-31.37
-22.14
-19.58
-18.65
-18.51
Total Expenditure (Excl Depreciation)
1,223.39
1,335.22
1,132.54
749.11
891.72
954.89
863.94
Operating Profit (PBDIT) excl Other Income
63
56.2
-24
-128.4
-140.29999999999998
-109.1
-125.5
Other Income
64.74
103.53
-129.49
494.47
157.16
26.76
125.04
Operating Profit (PBDIT)
229.34
267.49
-60.19
478.75
68.21
-35.53
14.15
Interest
106.31
95.69
107.72
56.70
28.55
18.93
16.55
Exceptional Items
-24.87
-112.88
-47.25
-213.94
93.36
-13.61
-79.34
Gross Profit (PBDT)
609.54
574.15
448.26
282.24
301.53
343.79
310.76
Depreciation
113.05
107.80
92.62
112.67
51.32
46.81
14.61
Profit Before Tax
-14.88
-48.88
-307.79
95.44
81.69
-114.89
-96.36
Tax
-15.28
40.52
148.13
17.20
7.45
2.28
-2.43
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-20.52
-108.91
-376.00
95.82
74.63
-115.58
-93.30
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-20.52
-108.91
-376.00
95.82
74.63
-115.58
-93.30
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
23.86
21.09
-75.27
-2.41
-0.38
-1.59
-0.62
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
3.35
-87.82
-451.26
93.42
74.25
-117.17
-93.93
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.01
0.01
0.01
0.01
0.01
0.01
0.01
Reserves
2,349.19
2,515.80
2,565.32
2,300.06
2,444.12
2,554.50
2,651.79
Earnings per share (EPS)
-0.02
-0.09
-0.31
0.08
0.06
-0.09
-0.11
Diluted Earnings per share
-0.02
-0.09
-0.31
0.08
0.06
-0.09
-0.11
Operating Profit Margin (Excl OI)
4.01%
4.04%
-2.1%
-20.68%
-18.67%
-12.9%
-17.0%
Gross Profit Margin
7.63%
4.23%
-19.41%
33.53%
17.7%
-8.05%
-11.07%
PAT Margin
-1.59%
-7.83%
-33.92%
15.44%
9.93%
-13.67%
-12.64%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2023 is -7.55% vs 25.51% in Mar 2022
Consolidate Net Profit
YoY Growth in year ended Mar 2023 is 103.76% vs 80.55% in Mar 2022
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2023 is 0.37% vs 136.65% in Mar 2022
Interest
YoY Growth in year ended Mar 2023 is 11.08% vs -11.14% in Mar 2022
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2023 has fallen from Mar 2022
Compare Annual Results Of Wai Yuen Tong Medicine Holdings Ltd. With
Figures in Million
Consolidate Annual Results
Change(HKD)
Change(%)
Net Sales
1,286.43
9,105.20
-7,818.77
-85.87%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,286.43
9,105.20
-7,818.77
-85.87%
Raw Material Cost
676.89
7,118.41
-6,441.52
-90.49%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
214.67
0.00
214.67
Power Cost
0
0
0.00
Manufacturing Expenses
106.31
45.93
60.38
131.46%
Selling and Distribution Expenses
544.61
986.87
-442.26
-44.81%
Other Expenses
-31.91
38.08
-69.99
-183.80%
Total Expenditure (Excl Depreciation)
1,223.39
8,531.97
-7,308.58
-85.66%
Operating Profit (PBDIT) excl Other Income
63.04
573.23
-510.19
-89.00%
Other Income
64.74
71.84
-7.10
-9.88%
Operating Profit (PBDIT)
229.34
1,216.07
-986.73
-81.14%
Interest
106.31
45.93
60.38
131.46%
Exceptional Items
-24.87
-0.08
-24.79
-30,987.50%
Gross Profit (PBDT)
609.54
1,986.79
-1,377.25
-69.32%
Depreciation
113.05
591.63
-478.58
-80.89%
Profit Before Tax
-14.88
578.43
-593.31
-102.57%
Tax
-15.28
50.89
-66.17
-130.03%
Provisions and contingencies
0.00
0
0.00
Profit After Tax
-20.52
509.61
-530.13
-104.03%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-20.52
509.61
-530.13
-104.03%
Share in Profit of Associates
0.00
0
0.00
Minority Interest
23.86
18.10
5.76
31.82%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
3.35
527.71
-524.36
-99.37%
Equity Capital
0
0
0.00
Face Value
0.01
1.06
0.00
Reserves
2,349.19
5,312.11
-2,962.92
-55.78%
Earnings per share (EPS)
-0.02
0.74
-0.76
-102.70%
Diluted Earnings per share
-0.02
0.74
-0.76
-102.70%
Operating Profit Margin (Excl OI)
4.01%
6.07%
0.00
-2.06%
Gross Profit Margin
7.63%
12.85%
0.00
-5.22%
PAT Margin
-1.59%
5.60%
0.00
-7.19%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 128.64 Million
in Mar 2023Figures in Million
YoY Growth in year ended Mar 2023 is -7.55% vs 25.51% in Mar 2022
Annual - Consolidate Net Profit
Consolidate Net Profit 0.33 Million
in Mar 2023Figures in Million
YoY Growth in year ended Mar 2023 is 103.76% vs 80.55% in Mar 2022
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 16.46 Million
in Mar 2023Figures in Million
YoY Growth in year ended Mar 2023 is 0.37% vs 136.65% in Mar 2022
Annual - Interest
Interest 10.63 Million
in Mar 2023Figures in Million
YoY Growth in year ended Mar 2023 is 11.08% vs -11.14% in Mar 2022
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 4.01%
in Mar 2023Figures in %
YoY Growth in year ended Mar 2023 has fallen from Mar 2022
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
